Fulvestrant (Faslodex)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Fulvestrant (Faslodex), covering 2012-12-06 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial) [Phase 2]